A recent study by the Society of Family Planning revealed that approximately 8,000 women per month receive abortion pills via mail in states where abortion is heavily restricted.
Access to medication abortion through telehealth continues to play an ever-increasing role in abortion care nationwide - even as the Supreme Court weighs the fate of telehealth abortion care.
While the Supreme Court has allowed mifepristone to remain on the market while the case moves through the courts, the Court could uphold a 5th Circuit holding that reimposed pre-2016 limitations on the medication.
If the Court affirms [the Fifth Circuit Court's ruling], the upshot will be harm all around: harm to women, particularly rural and low-income women, other basic rights - if a Court can override an agency's scientific conclusions on a drug - and to the medical profession.
Collection
[
|
...
]